PST

PST Inc. is a Japanese healthcare technology company specializing in the development of vocal biomarker technology and Software as a Medical Device (SaMD). The company utilizes proprietary voice pathology analysis to quantify mental and physical health conditions, providing objective indicators for stress, cognitive decline, and other pathophysiological states. Its core platform, VOISLOG, is designed for early detection and remote monitoring, supporting a 'B to B to C' business model that integrates with healthcare providers and corporate wellness programs. PST maintains a significant capital and business alliance with ROHTO Pharmaceutical and collaborates extensively with academic institutions like the University of Tokyo.